Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BLACKROCK INC BLK |
1,869,949 3.400% |
-2,729,329 (-59.34%) |
Filing History |
| 2024-04-25 5:51 pm Purchase |
2024-04-15 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Citadel Advisors LLC | 222,335 0.400% |
222,335 (New Position) |
Filing History |
| 2024-04-19 06:04 am Purchase |
2024-04-16 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
TANG CAPITAL PARTNERS LP | 4,502,857 8.200% |
4,502,857 (New Position) |
Filing History |
| 2024-02-14 4:18 pm Sale |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Lion Point Capital LP | 2,134,337 3.900% |
-2,645,311 (-55.35%) |
Filing History |
| 2024-02-14 3:07 pm Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Cormorant Asset Management LP | 3,250,000 5.960% |
450,000 (+16.07%) |
Filing History |
| 2024-02-14 12:18 pm Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Eventide Asset Management, LLC | 4,529,997 8.300% |
1,379,997 (+43.81%) |
Filing History |
| 2024-02-14 10:35 am Purchase |
2024-02-12 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
PRUDENTIAL FINANCIAL INC PRU |
3,309,991 6.070% |
3,309,991 (New Position) |
Filing History |
| 2024-02-14 10:06 am Sale |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 493,400 0.900% |
-3,021,956 (-85.96%) |
Filing History |
| 2024-02-14 09:04 am Unchanged |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 3,150,000 5.800% |
0 (Unchanged) |
Filing History |
| 2024-02-13 12:13 pm Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,463,641 9.990% |
491,981 (+9.90%) |
Filing History |
| 2024-02-08 1:56 pm Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
JENNISON ASSOCIATES LLC | 2,959,161 5.400% |
2,959,161 (New Position) |
Filing History |
| 2024-02-07 07:25 am Sale |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
ADAGE CAPITAL PARTNERS GP LLC | 2,581,250 4.730% |
-175,000 (-6.35%) |
Filing History |
| 2024-02-06 11:58 am Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
FRANKLIN RESOURCES INC BEN |
3,833,955 7.000% |
3,833,955 (New Position) |
Filing History |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BLACKROCK INC BLK |
4,599,278 8.400% |
3,657,967 (+388.60%) |
Filing History |
| 2023-10-10 4:01 pm Purchase |
2023-09-29 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Cormorant Asset Management LP | 2,800,000 5.530% |
2,800,000 (New Position) |
Filing History |
| 2023-07-06 4:20 pm Purchase |
2023-06-26 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
ADAGE CAPITAL PARTNERS GP LLC | 2,756,250 5.450% |
1,293,750 (+88.46%) |
Filing History |
| 2023-02-14 4:25 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 3,515,356 7.100% |
116,695 (+3.43%) |
Filing History |
| 2023-02-14 4:15 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Lion Point Capital LP | 4,779,648 9.900% |
1,150,026 (+31.68%) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Venrock Healthcare Capital Partners II, L.P. | 1,770,705 3.700% |
-1,109,391 (-38.52%) |
Filing History |
| 2023-02-14 2:35 pm Sale |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
683 Capital Management, LLC | 90,000 0.200% |
-1,842,829 (-95.34%) |
Filing History |